It has been today announced that they has received “Decision to grant” communications from the Canadian Intellectual Property Office and the Israel Patent Office for its patent applications CA3071...
Read moreThe financial services company Inveready, a member of Catalonia.health, announces the successful closure of its life sciences fund Inveready Innvierte Biotech II. This is the second fund the firm has ...
Read moreInvestigadores del Microfluidics Cluster del campus de Álava diseñan un sistema portátil, y económico para generar plasma rico en plaquetas de alta calidad
Read moreInvestigadores de la Universidad de Málaga y el IBIMA Plataforma BIONAND identifican un nuevo hallazgo contra el párkinson: una hormona presente en nuestro cuerpo muestra un potente efecto protector...
Read moreUn equipo del Instituto de Investigación Sanitaria Biogipuzkoa, del Departamento de Salud y Osakidetza, en colaboración con la EHU y el DIPC, ha desarrollado una nueva quimioterapia contra el colang...
Read moreOryzon Genomics, S.A. a clinical-stage biopharmaceutical company and a European leader in epigenetics, today announced that it continues to expand its patent portfolio for iadademstat and vafidemstat,...
Read moreThe Marqués de Valdecilla Research Institute (IDIVAL) is strengthening its commitment to healthcare innovation with a new project aimed at transforming the treatment of chronic and surgical wounds, o...
Read moreThe study demonstrates how the MAF Test®, which stratifies early-stage breast cancer patients by MAF gene status to guide adjuvant bisphosphonate therapy, delivers meaningful economic value across mu...
Read moreResearch grade recombinant protein expands toolkit of available CRISPR nucleases and increases efficiency of homology-directed repair (HDR) to enable more precise genome modifications
Read moreDeveloped under the principles of green chemistry, PLH is the first biocompatible, thermosetting and highly flexible copolyester on the market obtained from 100% bio- based raw materials. It is emergi...
Read moreOryzon Genomics today announced that the European Patent Office (EPO) has issued a Decision to Grant for its patent application EP20712594.9, entitled “Combinations of iadademstat for cancer therapy...
Read moreAM-Pharma B.V. today announced that it has successfully completed enrollment of patients in its ongoing Phase 2 clinical trial evaluating ilofotase alfa for the prevention of cardiac surgery-associate...
Read more